Four male individuals who were found to have two variants in CYP21A2 and whose genotypes suggested a potential diagnosis of non-classic CAH (characterised in males by mild signs of hyperandrogenism) were excluded from the secondary findings group. The gene discussed is CYP21A2; the disease is hyperandrogenism.